The Chemours Company (NYSE:CC) SVP Sells $154,800.00 in Stock

The Chemours Company (NYSE:CC) SVP Alvenia Scarborough sold 7,500 shares of Chemours stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $20.64, for a total transaction of $154,800.00. Following the transaction, the senior vice president now directly owns 16,645 shares in the company, valued at approximately $343,552.80. This represents a 31.06 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Chemours Stock Up 0.9 %

CC opened at $19.33 on Friday. The company has a fifty day moving average price of $19.09 and a 200-day moving average price of $21.86. The firm has a market capitalization of $2.89 billion, a P/E ratio of 38.66 and a beta of 1.75. The company has a debt-to-equity ratio of 6.05, a current ratio of 1.73 and a quick ratio of 0.92. The Chemours Company has a one year low of $15.10 and a one year high of $32.70.

Chemours (NYSE:CC) last released its quarterly earnings results on Monday, November 4th. The specialty chemicals company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.32 by $0.08. The firm had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.44 billion. Chemours had a net margin of 1.34% and a return on equity of 29.48%. The business’s revenue for the quarter was up .9% on a year-over-year basis. During the same period in the previous year, the business earned $0.64 EPS. Equities research analysts expect that The Chemours Company will post 1.35 earnings per share for the current fiscal year.

Chemours Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 15th will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 5.17%. The ex-dividend date of this dividend is Friday, November 15th. Chemours’s dividend payout ratio is presently 200.00%.

Institutional Trading of Chemours

Several institutional investors and hedge funds have recently bought and sold shares of CC. Norden Group LLC bought a new position in shares of Chemours during the first quarter valued at approximately $201,000. BNP Paribas Financial Markets increased its stake in shares of Chemours by 53.0% during the first quarter. BNP Paribas Financial Markets now owns 14,340 shares of the specialty chemicals company’s stock valued at $377,000 after purchasing an additional 4,965 shares in the last quarter. Texas Permanent School Fund Corp increased its stake in shares of Chemours by 1.4% during the first quarter. Texas Permanent School Fund Corp now owns 129,762 shares of the specialty chemicals company’s stock valued at $3,408,000 after purchasing an additional 1,736 shares in the last quarter. Swiss National Bank increased its stake in shares of Chemours by 0.4% during the first quarter. Swiss National Bank now owns 293,100 shares of the specialty chemicals company’s stock valued at $7,697,000 after purchasing an additional 1,300 shares in the last quarter. Finally, Inspire Investing LLC increased its stake in shares of Chemours by 12.1% during the first quarter. Inspire Investing LLC now owns 13,623 shares of the specialty chemicals company’s stock valued at $358,000 after purchasing an additional 1,466 shares in the last quarter. 76.26% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on CC shares. JPMorgan Chase & Co. dropped their target price on shares of Chemours from $25.00 to $18.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 6th. The Goldman Sachs Group lowered their price target on shares of Chemours from $29.00 to $23.00 and set a “neutral” rating on the stock in a report on Tuesday, September 3rd. Royal Bank of Canada lowered their price target on shares of Chemours from $28.00 to $25.00 and set an “outperform” rating on the stock in a report on Wednesday, November 6th. BMO Capital Markets lifted their price target on shares of Chemours from $30.00 to $32.00 and gave the stock an “outperform” rating in a report on Monday, October 7th. Finally, UBS Group lowered their price target on shares of Chemours from $30.00 to $28.00 and set a “buy” rating on the stock in a report on Tuesday, August 6th. Five equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, Chemours currently has a consensus rating of “Hold” and a consensus target price of $24.88.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.